Exalgo and Oxycodone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Exalgo (hydromorphone hydrochloride) and Oxycodone (oxycodone hydrochloride). Common drug interactions include impaired driving ability among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Exalgo and Oxycodone. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.

What is Exalgo?

Exalgo has active ingredients of hydromorphone hydrochloride. It is often used in chronic pain. eHealthMe is studying from 9,847 Exalgo users. Check the latest studies of Exalgo.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.



On Jul, 17, 2026

100 people who take Exalgo and Oxycodone together, and have interactions are studied.

Exalgo and Oxycodone drug interactions.

What are the common drug interactions of Exalgo and Oxycodone, by gender? *:

female:

  1. Impaired driving ability
  2. Palpitations (feelings or sensations that your heart is pounding or racing)
  3. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  4. Sleep disorder
  5. Thermal burn (burn by heat)
  6. Weight increased
  7. Cough
  8. Depression
  9. Swelling
  10. Asthenia (weakness)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Drug dependence
  4. Acute respiratory failure
  5. Anaemia (lack of blood)
  6. Apnoea (suspension of external breathing)
  7. Arthropathy
  8. Coagulopathy (blood's ability to clot is impaired)
  9. Confusional state
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

What are the common drug interactions of Exalgo and Oxycodone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)

30-39:

  1. Ankle fracture
  2. Disease progression
  3. Neuropathy peripheral (surface nerve damage)
  4. Tibia fracture (fracture of lower leg bone)
  5. Drug screen positive
  6. Weight increased

40-49:

  1. Cough
  2. Abdominal pain
  3. Arthralgia (joint pain)
  4. Asthenia (weakness)
  5. Butterfly rash
  6. Collagen disorder (infection and weakness of collagen)
  7. Depression
  8. Discomfort
  9. Dry skin
  10. Dysuria (painful or difficult urination)

50-59:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Acute respiratory failure
  3. Anaemia (lack of blood)
  4. Arthropathy
  5. Coagulopathy (blood's ability to clot is impaired)
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Drug administration error
  8. Enzyme level increased
  9. Hepatitis acute
  10. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

60+:

  1. Fall
  2. Balance disorder
  3. Hand fracture
  4. Head injury
  5. Traumatic haemorrhage (a bleeding due to trauma)
  6. Vomiting
  7. Muscle spasms (muscle contraction)
  8. Chest pain
  9. Dry skin
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Constipation: 26 people, 26.00%
  2. Depression: 23 people, 23.00%
  3. Stress And Anxiety: 23 people, 23.00%
  4. Muscle Spasms (muscle contraction): 22 people, 22.00%
  5. High Blood Cholesterol: 18 people, 18.00%
  6. High Blood Pressure: 18 people, 18.00%
  7. Insomnia (sleeplessness): 17 people, 17.00%
  8. Nausea (feeling of having an urge to vomit): 16 people, 16.00%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 15.00%
  10. Diabetes: 14 people, 14.00%

* Approximation only. Some reports may have incomplete information.

Do you take Exalgo and Oxycodone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Exalgo and Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exalgo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exalgo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycodone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydromorphone hydrochloride and oxycodone hydrochloride (the active ingredients of Exalgo and Oxycodone, respectively), and Exalgo and Oxycodone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: